Your browser doesn't support javascript.
loading
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030.
Parsons, Heather A; Blewett, Timothy; Chu, Xiangying; Sridhar, Sainetra; Santos, Katheryn; Xiong, Kan; Abramson, Vandana G; Patel, Ashka; Cheng, Ju; Brufsky, Adam; Rhoades, Justin; Force, Jeremy; Liu, Ruolin; Traina, Tiffany A; Carey, Lisa A; Rimawi, Mothaffar F; Miller, Kathy D; Stearns, Vered; Specht, Jennifer; Falkson, Carla; Burstein, Harold J; Wolff, Antonio C; Winer, Eric P; Tayob, Nabihah; Krop, Ian E; Makrigiorgos, G Mike; Golub, Todd R; Mayer, Erica L; Adalsteinsson, Viktor A.
Afiliação
  • Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Blewett T; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Chu X; Harvard Medical School, Boston, MA, USA.
  • Sridhar S; Broad Institute of MIT and Harvard, Boston, MA, USA.
  • Santos K; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Xiong K; Broad Institute of MIT and Harvard, Boston, MA, USA.
  • Abramson VG; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Patel A; Broad Institute of MIT and Harvard, Boston, MA, USA.
  • Cheng J; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Brufsky A; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Rhoades J; Broad Institute of MIT and Harvard, Boston, MA, USA.
  • Force J; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Liu R; Broad Institute of MIT and Harvard, Boston, MA, USA.
  • Traina TA; Duke Cancer Center, Durham, NC, USA.
  • Carey LA; Broad Institute of MIT and Harvard, Boston, MA, USA.
  • Rimawi MF; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Miller KD; The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Stearns V; Baylor College of Medicine Dan L. Duncan Comprehensive Cancer Center, Houston, TX, USA.
  • Specht J; Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA; Birmingham, AB, USA.
  • Falkson C; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Burstein HJ; Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Wolff AC; The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Winer EP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Tayob N; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Krop IE; Harvard Medical School, Boston, MA, USA.
  • Makrigiorgos GM; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.
  • Golub TR; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mayer EL; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Adalsteinsson VA; Harvard Medical School, Boston, MA, USA.
medRxiv ; 2023 Mar 08.
Article em En | MEDLINE | ID: mdl-36945501
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article